U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H33N7O2S
Molecular Weight 531.672
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LIT-001

SMILES

CN(C)C(=S)[C@@H]1CCCN1C(=O)NCC2=C(C)C=C(C=C2)C(=O)N3CC4=C(NC5=CC=CC=C35)N(C)N=C4

InChI

InChIKey=AOPORIRPXVMWSL-DEOSSOPVSA-N
InChI=1S/C28H33N7O2S/c1-18-14-19(11-12-20(18)15-29-28(37)34-13-7-10-24(34)27(38)32(2)3)26(36)35-17-21-16-30-33(4)25(21)31-22-8-5-6-9-23(22)35/h5-6,8-9,11-12,14,16,24,31H,7,10,13,15,17H2,1-4H3,(H,29,37)/t24-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
LIT-001
Common Name English
1-Pyrrolidinecarboxamide, N-[[4-[(4,10-dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-2-[(dimethylamino)thioxomethyl]-, (2S)-
Systematic Name English
(2S)-N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-2-[(dimethylamino)thioxomethyl]-1-pyrrolidinecarboxamide
Systematic Name English
Code System Code Type Description
CAS
2245072-20-0
Created by admin on Sat Dec 16 20:10:28 GMT 2023 , Edited by admin on Sat Dec 16 20:10:28 GMT 2023
PRIMARY
WIKIPEDIA
LIT-001
Created by admin on Sat Dec 16 20:10:28 GMT 2023 , Edited by admin on Sat Dec 16 20:10:28 GMT 2023
PRIMARY
PUBCHEM
145711714
Created by admin on Sat Dec 16 20:10:28 GMT 2023 , Edited by admin on Sat Dec 16 20:10:28 GMT 2023
PRIMARY
FDA UNII
Y6596259AE
Created by admin on Sat Dec 16 20:10:28 GMT 2023 , Edited by admin on Sat Dec 16 20:10:28 GMT 2023
PRIMARY